Unraveling the molecular mechanism of benzothiophene and benzofuran scaffold-merged compounds binding to anti-apoptotic Myeloid cell leukemia 1

References

• Akgul, C. (2009). Mcl-1 is a potential therapeutic target in multiple types of cancer. Cellular and Molecular Life Sciences, 66(8), 1326–1336. doi:10.1007/s00018-008-8637-6
   Google Scholar
• Balasubramanian, P. K., Balupuri, A., & Cho, S. J. (2016). Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: A combined approach. Archives of Pharmacal Research, 39(3), 328–339. doi:10.1007/s12272-015-0698-0
   Google Scholar
• Balasubramanian, P. K., Balupuri, A., Kang, H. Y., & Cho, S. J. (2017). Receptor-guided 3D-QSAR studies, molecular dynamics simulation and free energy calculations of Btk kinase inhibitors. BMC Systems Biology, 11, 6. doi:10.1186/s12918-017-0385-5
   Google Scholar
• Balasubramanian, P. K., Balupuri, A., Kothandan, G., & Cho, S. J. (2014). In silico study of 1-(4-phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl) ethanones derivatives as CCR1 antagonist: Homology modeling, docking and 3D-QSAR approach. Bioorganic & Medicinal Chemistry Letters, 24(3), 928–933. doi:10.1016/j.bmcl.2013.12.065
   Google Scholar
• Berman, H., Henrick, K., Nakamura, H., & Markley, J. L. (2007). The worldwide Protein Data Bank (wwPDB): Ensuring a single, uniform archive of PDB data. Nucleic Acids Research, 35, D301–D303. doi:10.1093/nar/gkl971
   Google Scholar
• Brooks, B. R., Janežič, D., & Karplus, M. (1995). Harmonic analysis of large systems. I. Methodology. Journal of Computational Chemistry, 16(12), 1522–1542. doi:10.1002/jcc.540161209
   Google Scholar
• Cao, X., Yap, J. L., Newell-Rogers, M. K., Peddaboina, C., Jiang, W., Papaconstantinou, H. T., … Smythe, R. W. (2013). The novel BH3 alpha-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak. Molecular Cancer, 12(1), 1–16. doi:10.1186/1476-4598-12-42
   Google Scholar
• Case, D. A., Betz, R. M., Botello-Smith, W., Cerutti, D. S., Cheatham, I. T. E., Darden, T. A., … Kollman, P. A. (2016). AMBER 16. San Francisco: University of California.
   Google Scholar
• Case, D. A., Cheatham, T. E. 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M. Jr., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. doi:10.1002/jcc.20290
   Google Scholar
• Cerutti, D. S., Duke, R. E., Darden, T. A., & Lybrand, T. P. (2009). Staggered Mesh Ewald: An extension of the Smooth Particle-Mesh Ewald method adding great versatility. Journal of Chemical Theory And Computation, 5(9), 2322–2338. doi:10.1021/ct9001015
   Google Scholar
• Craig, R. W. (2002). MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia, 16(4), 444–454. doi:10.1038/sj.leu.2402416
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle Mesh Ewald – An N⋅Log(N) method for Ewald Sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. doi:10.1063/1.464397
   Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10–11), 647–671. doi:10.1007/s10822-006-9087-6
   Google Scholar
• Feller, S. E., Zhang, Y. H., Pastor, R. W., & Brooks, B. R. (1995). Constant-pressure molecular-dynamics simulation – The Langevin Piston method. The Journal of Chemical Physics, 103(11), 4613–4621. doi:10.1063/1.470648
   Google Scholar
• Fire, E., Gulla, S. V., Grant, R. A., & Keating, A. E. (2010). Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes. Protein Science, 19(3), 507–519. doi:10.1002/pro.329.
   Google Scholar
• Fogha, J., Marekha, B., De Giorgi, M., Voisin-Chiret, A. S., Rault, S., Bureau, R., & Sopkova-de Oliveira Santos, J. (2017). Toward understanding Mcl-1 promiscuous and specific binding mode. Journal of Chemical Information and Modeling, 57(11), 2885–2895. doi:10.1021/acs.jcim.7b00396
   Google Scholar
• Foight, G. W., Ryan, J. A., Gulla, S. V., Letai, A., & Keating, A. E. (2014). Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells. ACS Chemical Biology, 9(9), 1962–1968. doi:10.1021/cb500340w
   Google Scholar
• Friberg, A., Vigil, D., Zhao, B., Daniels, R. N., Burke, J. P., Garcia-Barrantes, P. M., … Fesik, S. W. (2013). Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. Journal of medicinal chemistry, 56(1), 15–30. doi:10.1021/jm301448p
   Google Scholar
• Gilson, M. K., Sharp, K. A., & Honig, B. H. (1998). Calculating the electrostatic potential of molecules in solution: Method and error assessment. Journal of Computational Chemistry, 9, 327–335. doi:10.1002/jcc.540090407
   Google Scholar
• Koshy, C., Parthiban, M., & Sowdhamini, R. (2010). 100 ns molecular dynamics simulations to study intramolecular conformational changes in Bax. Journal of Biomolecular Structure and Dynamics, 28(1), 71–83. doi:10.1080/07391102.2010.10507344
   Google Scholar
• Lee, J. U., Hosotani, R., Wada, M., Doi, R., Kosiba, T., Fujimoto, K., … Imamura, M. (1999). Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. European Journal of Cancer, 35(9), 1374–1380.
   Google Scholar
• Lee, S., Wales, T. E., Escudero, S., Cohen, D. T., Luccarelli, J., Gallagher, C. G., … Walensky, L. D. (2016). Allosteric inhibition of antiapoptotic MCL-1. Nature Structural & Molecular Biology, 23(6), 600–607. doi:10.1038/nsmb.3223
   Google Scholar
• Liu, Q., Moldoveanu, T., Sprules, T., Matta-Camacho, E., Mansur-Azzam, N., & Gehring, K. (2010). Apoptotic regulation by MCL-1 through heterodimerization. The Journal of Biological Chemistry, 285(25), 19615–19624. doi:10.1074/jbc.M110.105452
   Google Scholar
• Liu, Q., & Wang, H. G. (2012). Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors. Communicative & Integrative Biology, 5(6), 557–565. doi:10.4161/cib.21554
   Google Scholar
• Marimuthu, P., Balasubramanian, P. K., & Singaravelu, K. (2017). Deciphering the crucial molecular properties of a series of benzothiazole hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein. Journal of Biomolecular Structure and Dynamics, 24, 1–14. doi:10.1080/07391102.2017.1365771
   Google Scholar
• Marimuthu, P., Lee, Y. J., Kim, B. H., & Seo, S. S. (2018). In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly. Journal of Biomolecular Structure and Dynamics, 12, 1–42. doi:10.1080/07391102.2018.1426046
   Google Scholar
• Marimuthu, P., & Singaravelu, K. (2017). Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis. Journal of Biomolecular Structure and Dynamics, 36(6), 1–12. doi:10.1080/07391102.2017.1331863
   Google Scholar
• Marimuthu, P., & Singaravelu, K. (2018). Prediction of hot spots at myeloid cell leukemia-1-inhibitors interface using energy estimation and alanine scanning mutagenesis. Biochemistry, 57(7), 1249–1261. doi:10.1021/acs.biochem.7b01048
   Google Scholar
• Marimuthu, P., Singaravelu, K., & Namasivayam, V. (2017). Probing the binding mechanism of mercaptoguanine derivatives as inhibitors of HPPK by docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35(16), 3507–3521. doi:10.1080/07391102.2016.1260496.
   Google Scholar
• Michels, J., Johnson, P. W., & Packham, G. (2005). Mcl-1. International Journal of Biochemistry & Cell Biology, 37(2), 267–271. doi:10.1016/j.biocel.2004.04.007.
   Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. doi:10.1021/Ct300418h
   Google Scholar
• Modi, V., & Sankararamakrishnan, R. (2017). Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides. Journal of Molecular Graphics and Modelling, 73, 115–128. doi:10.1016/j.jmgm.2016.12.006
   Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   Google Scholar
• Namasivayam, V., & Gunther, R. (2007). pso@autodock: A fast flexible molecular docking program based on Swarm intelligence. Chemical Biology & Drug Design, 70(6), 475–484. doi:10.1111/j.1747-0285.2007.00588.x
   Google Scholar
• Peddaboina, C., Jupiter, D., Fletcher, S., Yap, J. L., Rai, A., Tobin, R. P., … Cao, X. (2012). The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. BMC Cancer, 12, 541. doi:10.1186/1471-2407-12-541
   Google Scholar
• Pelz, N. F., Bian, Z., Zhao, B., Shaw, S., Tarr, J. C., Belmar, J., … Fesik, S. W. (2016). Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods. Journal of Medicinal Chemistry, 59(5), 2054–2066. doi:10.1021/acs.jmedchem.5b01660
   Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., … Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. doi:10.1002/jcc.20289
   Google Scholar
• Placzek, W. J., Sturlese, M., Wu, B., Cellitti, J. F., Wei, J., & Pellecchia, M. (2011). Identification of a novel Mcl-1 protein binding motif. The Journal of Biological Chemistry, 286(46), 39829–39835. doi:10.1074/jbc.M111.305326
   Google Scholar
• Roe, D. R., & Cheatham, T. E. 3rd. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. doi:10.1021/ct400341p
   Google Scholar
• Ryckaer, J., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Chemical Physics, 23(3), 327–341. doi:10.1016/0021-9991(77)90098-5
   Google Scholar
• Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24(5), 417–422. doi:10.1007/s10822-010-9352-6
   Google Scholar
• Senthilkumar, R., Marimuthu, P., Paul, P., Manojkumar, Y., Arunachalam, S., Eriksson, J. E., & Johnson, M. S. (2016). Plasma protein binding of anisomelic acid: Spectroscopy and molecular dynamic simulations. Journal of Chemical Information and Modeling, 56(12), 2401–2412. doi:10.1021/acs.jcim.6b00445
   Google Scholar
• Shivakumar, D., Williams, J., Wu, Y. J., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. Journal of Chemical Theory and Computation, 6(5), 1509–1519. doi:10.1021/Ct900587b
   Google Scholar
• Stewart, M. L., Fire, E., Keating, A. E., & Walensky, L. D. (2010). The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer. Nature Chemical Biology, 6(8), 595–601. doi:10.1038/nchembio.391
   Google Scholar
• Tsui, V., & Case, D. A. (2000). Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers, 56(4), 275–291. doi:10.1002/1097-0282(2000)56:4 < 275::AID-BIP10024 > 3.0.CO;2-E
   Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. doi:10.1002/jcc.20035
   Google Scholar
• Wesarg, E., Hoffarth, S., Wiewrodt, R., Kroll, M., Biesterfeld, S., Huber, C., & Schuler, M. (2007). Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. International Journal of Cancer, 121(11), 2387–2394. doi:10.1002/ijc.22977
   Google Scholar